Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs

19Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Benzene affects hematopoietic progenitor cells leading to bone marrow depression and genotoxic effects such as micronucleus formation. Progenitor cell proliferation and differentiation are inhibited by prostaglandins produced by macrophages. Administration of benzene DBA/2 or C57BL/6 mice caused a dose-dependent bone marrow depression and a significant increase in marrow prostaglandin E level and both were prevented by the coadministration of indomethacin and other inhibitors of the cyclooxygenase component of prostaglandin H synthase. Levels of benzene that decreased bone marrow cellularity also caused genotoxic effects measured as increased micronucleated polychromatic erythrocytes in peripheral blood, which was also prevented by the coadministration of indomethacin. These results suggest a possible role for prostaglandin synthase in benzene myelotoxicity; a mechanism by which this might occur is presented.

Cite

CITATION STYLE

APA

Kalf, G. F., Schlosser, M. J., Renz, J. F., & Pirozzi, S. J. (1989). Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs. Environmental Health Perspectives, 82, 57–64. https://doi.org/10.1289/ehp.898257

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free